Home › All posts by Company Secretary
Archives
September 27, 2018

Invion spin-off Chronic Airway Therapeutics selects leading CRO for the future development of nadolol

September 26, 2018

New formulation of Photosoft therapy shows increased effect in ovarian cancer

September 10, 2018

Photosoft granted patent protection in Australia

September 7, 2018

Demerger of respiratory assets – clarification on eligible shareholders

September 5, 2018

Invion to spinout respiratory assets and advance clinical development in China

August 28, 2018

Financial Report for the year ended 30 June 2018

July 5, 2018

Photosoft efficiently destroys ovarian cancer cells in vitro

April 30, 2018

Investor Update

March 21, 2018

Leading ovarian cancer expert Dr Andrew Stephens appointed to Invion’s advisory board

March 20, 2018

Invion secures research alliance with Hudson Institute of Medical Research